Indian Journal of Orthopaedics Surgery · Jul 24, 2026

Efficacy and safety of oral versus high dose intramuscular vitamin D therapy in elderly patients: A randomized controlled study

By Ballatigi S, Hanumanthareddy C, Lingareddy P

Background: Vitamin D deficiency is common in elderly individuals and contributes to osteoporosis, sarcopenia, impaired balance, and increased fracture risk. Although oral vitamin D supplementation is widely used, adherence and variable absorption may reduce its effectiveness. High-dose intramuscular (IM) vitamin D may provide sustained serum levels with improved compliance. This study compared the efficacy and safety of oral versus high-dose IM vitamin D therapy in elderly patients with vitamin D deficiency. Materials and Methods: In this prospective randomized controlled study, 100 patients aged >65 years with vitamin D deficiency were randomized to receive either oral cholecalciferol 60,000 IU weekly for 10 weeks (n=50) or a single 600,000 IU IM injection (n=50). Serum 25-hydroxyvitamin D [25(OH)D], calcium, phosphorus, parathyroid hormone (PTH), urinary calcium/creatinine ratio, quadriceps muscle strength, and Short Physical Performance Battery (SPPB) scores were assessed up to 6 months. Safety outcomes included hypercalcemia, hypercalciuria, renal stones, and vitamin D toxicity.Results: Both groups showed significant increases in serum 25(OH)D levels and reductions in PTH from baseline. The oral group demonstrated a greater early increase at 6 weeks, whereas the IM group maintained significantly higher vitamin D levels at 12 weeks and 6 months (p

doi.org/10.18231/j.ijos.16808.1780467980Open accessInterventions

AgingResearch.News